ABSTRACT
Elevated levels of the inflammatory cytokine interleukin-6 (IL-6) occur in a number of CNS disorders. However, little is known about how this condition affects CNS neuronal function. Transgenic mice that express elevated levels of IL-6 in the CNS show cognitive changes, increased propensity for hippocampal seizures and reduced number of inhibitory interneurons, suggesting that elevated levels of IL-6 can cause neuroadaptive changes that alter hippocampal function. To identify these neuroadaptive changes, we measured the levels of protein expression using Western blot analysis and synaptic function using field potential recordings in hippocampus from IL-6 transgenic mice (IL-6 tg) and their non-transgenic (non-tg) littermates. Western blot analysis showed enhanced levels of the GFAP and STAT3 in the IL-6 tg hippocampus compared with the non-tg hippocampus, but no difference for several other proteins. Field potential recordings of synaptic transmission at the Schaffer collateral to CA1 synapse showed enhanced dendritic excitatory postsynaptic potentials and somatic population spikes in the CA1 region of hippocampal slices from IL-6 tg mice compared with slices from non-tg littermate controls. No differences were observed for several forms of short-term and long-term synaptic plasticity between hippocampal slices from IL-6 tg and non-tg mice. These results demonstrate that elevated levels of IL-6 can alter mechanisms involved in the excitability of hippocampal neurons and synapses, an effect consistent with recent evidence indicating that elevated production of IL-6 plays an important role in conditions associated with seizure activity and in other impairments observed in CNS disorders with a neuroinflammatory component.
Subject(s)
Central Nervous System/metabolism , Hippocampus/physiology , Interleukin-6/biosynthesis , Interleukin-6/genetics , Synaptic Transmission/genetics , Animals , Blotting, Western , CA1 Region, Hippocampal/metabolism , CA1 Region, Hippocampal/physiology , Dendrites/drug effects , Dendrites/physiology , Electrophysiological Phenomena , Excitatory Postsynaptic Potentials/physiology , Female , Glial Fibrillary Acidic Protein/metabolism , Long-Term Potentiation/drug effects , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , STAT3 Transcription Factor/metabolismABSTRACT
Simian immunodeficiency virus (SIV) infection of rhesus monkeys provides an excellent model of the central nervous system (CNS) consequences of HIV infection. To discern the relationship between viral load and abnormalities induced in the CNS by the virus, we infected animals with SIV and later instituted antiviral treatment to lower peripheral viral load. Measurement of sensory-evoked potentials, assessing CNS neuronal circuitry, revealed delayed latencies after infection that could be reversed by lowering viral load. Cessation of treatment led to the reappearance of these abnormalities. In contrast, the decline in general motor activity induced by SIV infection was unaffected by antiviral treatment. An acute increase in the level of the chemokine monocyte chemoattractant protein-1 (MCP-1) was found in the cerebrospinal fluid (CSF) relative to plasma in the infected animals at the peak of acute viremia, likely contributing to an early influx of immune cells into the CNS. Examination of the brains of the infected animals after return of the electrophysiological abnormalities revealed diverse viral and inflammatory findings. Although some of the physiological abnormalities resulting from SIV infection can be at least temporarily reversed by lowering viral load, the viral-host interactions initiated by infection may result in long-lasting changes in CNS-mediated functions.
Subject(s)
Antiviral Agents/therapeutic use , Brain/physiopathology , Movement Disorders/drug therapy , Simian Acquired Immunodeficiency Syndrome/drug therapy , Animals , Blood-Brain Barrier , Brain/drug effects , Brain/virology , Evoked Potentials, Auditory, Brain Stem/drug effects , Macaca mulatta , Motor Activity/drug effects , Simian Acquired Immunodeficiency Syndrome/physiopathology , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/isolation & purificationABSTRACT
The hypocretins (hcrts), also known as orexins, are two recently identified excitatory neuropeptides that in rat are produced by approximately 1200 neurons whose cell bodies are located in the lateral hypothalamus. The hypocretins/orexins have been implicated in the regulation of rapid eye movement (REM) sleep and the pathophysiology of narcolepsy. In the present study, we investigated whether the locus coeruleus (LC), a structure receiving dense hcrtergic innervation, which is quiescent during REM sleep, might be a target for hcrt to regulate REM sleep. Local administration of hcrt1 but not hcrt2 in the LC suppressed REM sleep in a dose-dependent manner and increased wakefulness at the expense of deep, slow-wave sleep. These effects were blocked with an antibody that neutralizes hcrt binding to hcrt receptor 1. In situ hybridization and immunocytochemistry showed the presence of hcrt receptor 1 but not the presence of hcrt receptor 2 in the LC. Iontophoretic application of hcrt1 enhanced the firing rate of LC neurons in vivo, and local injection of hcrt1 into the LC induced the expression of c-fos in the LC area. We propose that hcrt receptor 1 in the LC is a key target for REM sleep regulation and might be involved in the pathophysiological mechanisms of narcolepsy.
Subject(s)
Carrier Proteins/metabolism , Intracellular Signaling Peptides and Proteins , Locus Coeruleus/metabolism , Neurons/metabolism , Neuropeptides/metabolism , Sleep, REM/physiology , Animals , Antibodies/pharmacology , Carrier Proteins/administration & dosage , Dose-Response Relationship, Drug , Immunohistochemistry , In Situ Hybridization , Iontophoresis , Locus Coeruleus/cytology , Locus Coeruleus/drug effects , Locus Coeruleus/physiopathology , Male , Microinjections , Neurons/cytology , Neurons/drug effects , Neuropeptides/administration & dosage , Orexin Receptors , Orexins , Polysomnography , Proto-Oncogene Proteins c-fos/biosynthesis , Rats , Rats, Sprague-Dawley , Reaction Time/drug effects , Receptors, G-Protein-Coupled , Receptors, Neuropeptide/antagonists & inhibitors , Receptors, Neuropeptide/metabolism , Sleep/drug effects , Sleep/physiology , Sleep Disorders, Circadian Rhythm/chemically induced , Sleep Disorders, Circadian Rhythm/physiopathology , Sleep, REM/drug effects , Wakefulness/drug effects , Wakefulness/physiologyABSTRACT
Six rhesus monkeys were trained to stable performance on neuropsychological tests of memory, reinforcer efficacy, reaction time and bimanual motor coordination. Three monkeys were then exposed to a high-dose, short course regimen of (+/-)3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") (4 days, 10 mg/kg i.m., b.i.d.). Following treatment, concentrations of 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF) were reduced by approximately 50% in the treated animals, and this effect persisted for approximately three months post-MDMA. Behavioral performance was disrupted during acute MDMA treatment but returned to baseline within one week following treatment. MDMA also produced persistent alterations in late peak latencies of brainstem auditory evoked potentials (BSAEP), lasting three months post-MDMA. Both CSF 5-HIAA concentrations and evoked potential latencies were normalized four months after treatment. These findings indicate that serotonergic alterations associated with MDMA use may result in persisting changes in brain function.
Subject(s)
Brain/drug effects , Macaca mulatta/psychology , Memory Disorders/chemically induced , N-Methyl-3,4-methylenedioxyamphetamine/toxicity , Neuropsychological Tests/standards , Psychomotor Performance/physiology , Animals , Behavior, Animal/drug effects , Cognition/drug effects , Dose-Response Relationship, Drug , Evoked Potentials, Auditory, Brain Stem/drug effects , Evoked Potentials, Auditory, Brain Stem/physiology , Hydroxyindoleacetic Acid/cerebrospinal fluid , Hydroxyindoleacetic Acid/chemistry , Male , N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage , Psychomotor Performance/drug effects , Serotonin/metabolism , Time FactorsABSTRACT
Potential interactions between psychostimulant drugs and infection with feline immunodeficiency virus (FIV) on brain metabolism were evaluated. Four groups of cats were studied: control, FIV positive, methamphetamine (MA) exposed, and FIV positive plus MA exposed. Frontal gray matter, frontal white matter, and caudate brain extracts were studied with proton magnetic resonance spectroscopy (1HMRS). In the frontal white matter, FIV-infected cats showed decreases in creatine and choline, while MA-treated cats had elevated gamma-aminobutyric acid (GABA). The decreased glutamate in FIV cats normalized with MA exposure. FIV and MA both affect brain metabolites individually and combined. 1HMRS is useful for evaluating the effects of FIV and drug abuse in the brain.
Subject(s)
Acquired Immunodeficiency Syndrome , Brain/drug effects , Brain/virology , Immunodeficiency Virus, Feline , Magnetic Resonance Spectroscopy/methods , Methamphetamine/pharmacology , Acquired Immunodeficiency Syndrome/metabolism , Acquired Immunodeficiency Syndrome/virology , Animals , Brain/anatomy & histology , Brain/metabolism , Brain Chemistry , Cats , Choline/metabolism , Creatine/metabolism , Disease Models, Animal , Infections , Random Allocation , gamma-Aminobutyric Acid/metabolismABSTRACT
Administration of PCPA, a specific inhibitor of serotonin synthesis, induced a significant decrease of total sleep time in the lizard Ctenosaura pectinata. This effect was exerted on both quiet sleep and active sleep, but it was more intense on active sleep. Reduction in the amount of active sleep was due to a decrease in the number of the episodes not in their mean duration, since this parameter increased significantly from 5.97 s, under control conditions, to 11.77 s, 10.66 s and 8.85 s at 24, 48 and 72 h after PCPA injection, respectively. Neurochemical analysis showed a significant decrease in the amount of serotonin in the analyzed brain stem structures 12 h after PCPA administration. The possible participation of serotonergic mechanisms in the regulation of reptilian sleep is discussed.
Subject(s)
Catecholamines/metabolism , Fenclonine/pharmacology , Serotonin Agents/pharmacology , Serotonin/metabolism , Sleep/drug effects , Animals , Brain Chemistry/drug effects , Electrophysiology , Female , Lizards , Male , Species Specificity , Time FactorsABSTRACT
Close to 20% of the patients infected with the AIDS virus develops neurological deficit; eventhough HIV does not invade neurons. Consistently with the neurological deficit, HIV(+) subjects show abnormalities in brainstem auditory and visual evoked potentials (BSAEP and VEP) and in sleep patterns. The HIV-derived glycoprotein 120 has been postulated as a neurotoxic; therefore, it may be playing a crucial role in the generation of BSAEP and VEP, as well as in sleep disturbances. To study the role of the virus-derived proteins on the development of these electrophysiological signals' alterations, we have used the feline immunodeficiency virus (FIV)-derived gp120 and evaluated the changes in these electrophysiological signals. We employed 15 adult male Sprague-Dawley rats (250-350 g), chronically implanted for evoked potential and sleep recordings. Results showed that the i.c.v. administration of FIVgp120 (5 ng/10 microliter) produces changes in the latency of both cortical auditory evoked potentials (CAEPs) and VEPs and a decrease in both REM sleep and SWS. These data support the notion that FIVgp120 is neurotoxic to the central nervous system of cats and rats and that this protein suffices to cause electrophysiological alterations. In addition, it suggests that a similar effect may be occurring in humans as a result of HIVgp120's neurotoxic effects.
Subject(s)
Evoked Potentials, Auditory, Brain Stem/drug effects , Evoked Potentials, Visual/drug effects , Immunodeficiency Virus, Feline , Viral Envelope Proteins/pharmacology , Analysis of Variance , Animals , Cats , Male , Rats , Rats, Sprague-Dawley , Sleep/drug effects , Wakefulness/drug effectsABSTRACT
Polysomnographic studies were done at hourly intervals during 0.00, 0.35, 0.75 and 1.50 ppm of ozone (O3) exposure. We found a significant decrease in paradoxical sleep after 2 h and an increase in slow wave sleep after 12 h at all concentrations of O3. High resolution liquid chromatography demonstrated an increase in 5-HT concentration in the rat pons, in a roughly stepwise fashion as the O3 concentration increased. We propose that reaction products derived from O3 exposure, such as prostaglandins, could be affecting those physiological and biochemical mechanisms critical for the generation and maintenance of the sleep-wake cycle.
Subject(s)
Oxidants, Photochemical/pharmacology , Ozone/pharmacology , Pons/metabolism , Serotonin/metabolism , Sleep/drug effects , Wakefulness/drug effects , Animals , Arousal/drug effects , Electrodes, Implanted , Male , Polysomnography/drug effects , Pons/drug effects , Rats , Rats, Wistar , Sleep, REM/drug effectsABSTRACT
Sleep alterations and brain regional changes of serotonin were studied in rats exposed to 1.5 ppm of ozone (O3). Results showed a significant decrease in the time spent in wakefulness (W) and paradoxical sleep (PS) and a significant increase in the time spent in slow wave sleep (SWS). Neurochemical analysis showed a significant increase in the metabolism of serotonin in medulla oblongata, pons and midbrain, while both serotonin and its metabolite were reduced in hypothalamus. Although other neurotransmitters could be affected by O3 exposure, the sleep disorders observed in the present work may be related to alterations in the metabolism of serotonin produced by the exposure to O3.
Subject(s)
Brain Chemistry/drug effects , Ozone/toxicity , Serotonin/metabolism , Sleep Stages/drug effects , Sleep Wake Disorders/chemically induced , Animals , Chromatography, High Pressure Liquid , Hydroxyindoleacetic Acid/analysis , Male , Organ Specificity , Ozone/pharmacology , Polysomnography , Rats , Rats, Wistar , Sleep Wake Disorders/metabolism , Wakefulness/drug effectsABSTRACT
Specimens of the lizard Ctenosaura pectinata were chronically implanted for polygraphic recordings. Four different vigilance states were observed throughout the nyctohemeral cycle: Active wakefulness (Aw), quiet wakefulness (Qw), quiet sleep (Qs) and active sleep (As). Each state displayed its own behavioral and electrophysiological characteristics. Aw, Qw, Qs and As occupied 5.9%, 25.7%, 67.7% and 0.6% of the 24-h period, respectively. The frequency and the duration of As episodes showed great interanimal variability and the mean duration was very short (12.9 +/- 9 s, mean +/- standard deviation). Stimuli reaction threshold was highest during sleep. It is concluded that the lizard Ctenosaura pectinata exhibits two sleep phases (Qs and As) that may be assimilated to slow wave sleep (SWS) and paradoxical sleep (PS) of birds and mammals.
Subject(s)
Circadian Rhythm/physiology , Lizards/physiology , Sleep Stages/physiology , Animals , Arousal/physiology , Cerebral Cortex/physiology , Electroencephalography , Evoked Potentials/physiology , Sleep, REM/physiology , Wakefulness/physiologyABSTRACT
The brain stem of the lizard Ctenosaura pectinata was studied in 10 microns thick sections following the Nissl and eosin-hematoxilin techniques. Furthermore, the distribution of serotonin-containing neuronal somata in this encephalic region was determined by means of an indirect immunofluorescence technique using a specific antibody to serotonin. Two of the cellular groups of the brain stem were identified as the superior and inferior raphe nuclei, which show serotonergic cells of variable size (between 17 and 30 microns). The results obtained in the present study together with information coming from other authors, suggest that serotonergic neuronal systems placed at brain stem level of vertebrates are phylogenetically ancient.
Subject(s)
Lizards/anatomy & histology , Raphe Nuclei/anatomy & histology , Serotonin/physiology , Animals , Brain Mapping , Fluorescent Antibody Technique , Neurons/ultrastructure , Species SpecificityABSTRACT
Oleamide (cis-9,10-octadecenoamide) is a brain lipid that has recently been isolated from the cerebral fluid of sleep-deprived cats. Intracerebroventricular and intraperitoneal administration of oleamide induces sleep in rats. However, it is unclear whether oleamide's hypnogenic effects are mediated, in part, by its actions on blood pressure and core body temperature. Here we show that systemic administration of oleamide (10 and 20 mg/kg) in rats increased slow-wave sleep 2, without affecting blood pressure and heart rate. In addition, oleamide decreased body temperature and locomotor activity in a dose-dependent manner. These latter effects were not correlated in time with the observed increases in slow-wave sleep. These data suggest that the hypnogenic effects of oleamide are not related to changes in blood pressure, heart rate, or body temperature.
Subject(s)
Blood Pressure/drug effects , Body Temperature/drug effects , Motor Activity/drug effects , Oleic Acids/administration & dosage , Sleep/drug effects , Animals , Behavior, Animal/drug effects , Dose-Response Relationship, Drug , Handling, Psychological , Heart Rate/drug effects , Injections, Intraperitoneal , Injections, Intraventricular , Male , Rats , Rats, Sprague-DawleyABSTRACT
Feline immunodeficiency virus (FIV), a lentivirus, causes progressive immunosuppression and neurologic dysfunction in cats. Glucocorticoids are common therapeutic agents that are also immunosuppressive, and their use might enhance the pathogenic effects of lentivirus infections. Methylprednisolone acetate, a long-acting glucocorticoid, was administered to cats before FIV inoculation, and the course of early infection was monitored. The humoral immune response to FIV was not affected by corticosteroid treatment, but CD8+ cell-mediated antiviral activity was poor in cultures from FIV-infected cats treated with methylprednisolone. Steroid-treated cats had higher plasma viral RNA levels than untreated cats during acute viremia. In contrast, FIV-associated changes in brain stem auditory-evoked potentials were slow to develop in the methylprednisolone-treated cats. Methylprednisolone treatment of cats with established FIV infections appeared to reverse these neurophysiologic changes. These results emphasize the complexity of host-lentivirus interactions and suggest potential advantages and drawbacks of using glucocorticoids in lentivirus infections.
Subject(s)
Anti-Inflammatory Agents/pharmacology , Evoked Potentials, Auditory, Brain Stem/drug effects , Feline Acquired Immunodeficiency Syndrome/immunology , Feline Acquired Immunodeficiency Syndrome/physiopathology , Immunodeficiency Virus, Feline/physiology , Methylprednisolone/analogs & derivatives , Animals , Antibodies, Viral/blood , Antigens, Viral/blood , CD4-CD8 Ratio/drug effects , CD8-Positive T-Lymphocytes/immunology , Cats , Feline Acquired Immunodeficiency Syndrome/pathology , Feline Acquired Immunodeficiency Syndrome/virology , Immunodeficiency Virus, Feline/immunology , Immunodeficiency Virus, Feline/isolation & purification , Lymphocyte Subsets/drug effects , Methylprednisolone/pharmacology , Methylprednisolone Acetate , RNA, Viral/blood , Reverse Transcriptase Polymerase Chain Reaction , Tumor Necrosis Factor-alpha/metabolism , Viremia/virologyABSTRACT
Central nervous system (CNS) damage and dysfunction are devastating consequences of HIV infection. Although the CNS is one of the initial targets for HIV infection, little is known about early viral-induced abnormalities that can affect CNS function. Here we report the detection of early physiological abnormalities in simian immunodeficiency virus-infected monkeys. The acute infection caused a disruption of the circadian rhythm manifested by rises in body temperature, observed in all five individuals between 1 and 2 weeks postinoculation (p.i.), accompanied by a reduction in daily motor activity to 50% of control levels. Animals remained hyperthermic at 1 and 2 months p.i. and returned to preinoculation temperatures at 3 months after viral inoculation. Although motor activity recovered to baseline values at 1 month p.i., activity levels then decreased to approximately 50% of preinoculation values over the next 2 months. Analysis of sensory-evoked responses 1 month p.i. revealed distinct infection-induced changes in auditory-evoked potential peak latencies that persisted at 3 months after viral inoculation. These early physiological abnormalities may precede the development of observable cognitive or motor deficiencies and can provide an assay to evaluate agents to prevent or alleviate neuronal dysfunction.
Subject(s)
Brain/physiopathology , Simian Acquired Immunodeficiency Syndrome/physiopathology , Simian Immunodeficiency Virus/isolation & purification , Animals , Body Temperature , Circadian Rhythm , Macaca mulatta , Male , Motor ActivityABSTRACT
Four individuals of the lizard Ctenosaura pectinata were chronically implanted for electroencephalographic (EEG), electromyographic (EMG) and electro-oculographic (EOG) recordings. Four different vigilance states were observed throughout the nyctohemeral cycle. These states were: Active wakefulness (Aw), quiet wakefulness (Qw), quiet sleep (Qs) and active sleep (As). Each state displayed its own behavioral and electrophysiological characteristics. EEG waves were similar during Aw and Qw but they diminished in amplitude and frequency when passing from these states to Qs, and both parameters increased during As. Muscular activity was intense in Aw, it decreased during Qw and almost disappeared during Qs. This activity reappeared in a phasic way during As, coinciding with generalized motor manifestations. Ocular activity was intense during Aw but minimal during Qw, it disappeared in Qs and was present intermittently in As. Aw, Qw, Qs and As occupied 5.9%, 25.7%, 67.7% and 0.6% of the 24 hr period, respectively. The frequency and duration of As episodes showed great inter-animal variability and the mean duration was of 12.9 sec. Stimuli reaction threshold was highest during sleep. In conclusion, the lizard Ctenosaura pectinata exhibit two sleep phases (Qs and As) that may be assimilated to slow wave sleep (SWS) and paradoxical sleep (PS) of birds and mammals.
Subject(s)
Lizards/physiology , Sleep Stages/physiology , Wakefulness/physiology , Animals , Arousal/physiology , Electroencephalography , Electromyography , Electrooculography , Motor ActivityABSTRACT
One of the consequences of HIV infection is damage to the CNS. To characterize the virologic, immunologic, and functional factors involved in HIV-induced CNS disease, we analyzed the viral loads and T cell infiltrates in the brains of SIV-infected rhesus monkeys whose CNS function (sensory evoked potential) was impaired. Following infection, CNS evoked potentials were abnormal, indicating early CNS disease. Upon autopsy at 11 wk post-SIV inoculation, the brains of infected animals contained over 5-fold more CD8(+) T cells than did uninfected controls. In both infected and uninfected groups, these CD8(+) T cells presented distinct levels of activation markers (CD11a and CD95) at different sites: brain > CSF > spleen = blood > lymph nodes. The CD8(+) cells obtained from the brains of infected monkeys expressed mRNA for cytolytic and proinflammatory molecules, such as granzymes A and B, perforin, and IFN-gamma. Therefore, the neurological dysfunctions correlated with increased numbers of CD8(+) T cells of an activated phenotype in the brain, suggesting that virus-host interactions contributed to the related CNS functional defects.
Subject(s)
AIDS Dementia Complex/etiology , Brain Diseases/etiology , Brain/immunology , CD8-Positive T-Lymphocytes/immunology , Lymphocyte Activation , Simian Acquired Immunodeficiency Syndrome/immunology , Animals , CD28 Antigens/analysis , Immunophenotyping , Lymphocyte Function-Associated Antigen-1/analysis , Macaca mulatta , Simian Acquired Immunodeficiency Syndrome/complications , fas Receptor/analysisABSTRACT
Drug abuse is a common method of human immunodeficiency virus type 1 transmission, but the role of opiates on lentivirus disease progression is not well understood. The feline immunodeficiency virus (FIV)/cat system was used to model the weekend opiate abuser: the nondependent, nonaddicted, and nontolerant person. Sixteen cats were placed into 4 groups: FIV only, morphine only, morphine/FIV, and controls. Multiple acute morphine exposure did not increase the severity of early lentivirus infection. On the contrary, it delayed or moderated the FIV-induced disease progression. Although the animals were exposed to only 1 injection of morphine per day for 2 consecutive days per week, the morphine-treated FIV-infected animals had a delayed onset of the FIV-induced lymphadenopathy, did not develop or had a significant delay in the FIV-induced effects on brain stem auditory evoked potentials, and demonstrated a trend toward decreased virus load.
Subject(s)
Disease Models, Animal , Feline Acquired Immunodeficiency Syndrome/physiopathology , Morphine/toxicity , Substance-Related Disorders/complications , Animals , Cats , Disease Progression , HIV Infections/transmission , Hydrocortisone/blood , Illicit Drugs/adverse effects , Immunodeficiency Virus, Feline/genetics , Immunodeficiency Virus, Feline/isolation & purification , Morphine/administration & dosage , Morphine Dependence/complications , Reverse Transcriptase Polymerase Chain Reaction , Tumor Necrosis Factor-alpha/analysis , Tumor Necrosis Factor-alpha/cerebrospinal fluid , Viremia/diagnosisABSTRACT
Cortistatin-14 (CST-14) is a putative novel neuropeptide that shares 11 of its 14 residues with somatostatin-14 (SRIF-14), yet its effects on sleep physiology, locomotor behavior and hippocampal function are different from those of somatostatin. We studied the structural basis for cortistatin's distinct biological activities. As with SRIF-14, CST-14 does not show any preferred conformation in solution, as determined by circular dichroism and nuclear magnetic resonance. Synthetic cortistatin analogs were designed and synthesized based on the cyclic structure of octreotide. Biological assays were carried out to determine their binding affinities to five somatostatin receptors (sstl-5) and their ability to produce changes in locomotor activity and to modulate hippocampal physiology and sleep. The results show that the compound with N-terminal proline and C-terminal lysine amide exhibits cortistatin-like biological activities, including reduction of population spike amplitudes in the hippocampal CA1 region, decrease in locomotor activity and enhancement of slow-wave sleep 2. These findings suggest that both proline and lysine are necessary for cortistatin binding to its specific receptor.
Subject(s)
Cerebral Ventricles/physiology , Motor Activity/drug effects , Neuropeptides/pharmacology , Receptors, Somatostatin/metabolism , Sleep Stages/drug effects , Somatostatin/pharmacology , Amino Acid Sequence , Animals , CHO Cells , Cerebral Ventricles/drug effects , Cricetinae , Dose-Response Relationship, Drug , Electrophysiology/methods , Humans , Injections, Intraventricular , Male , Mice , Neuropeptides/administration & dosage , Neuropeptides/chemistry , Octreotide/administration & dosage , Octreotide/chemistry , Octreotide/pharmacology , Oligopeptides/chemical synthesis , Oligopeptides/chemistry , Oligopeptides/pharmacology , Protein Conformation , Radioligand Assay , Rats , Rats, Sprague-Dawley , Recombinant Proteins/metabolism , Sleep, REM/drug effects , Somatostatin/administration & dosage , Somatostatin/chemistry , Structure-Activity Relationship , TransfectionABSTRACT
A model is proposed in which a neurovirulent, microglial-passaged, simian immunodeficiency virus (SIV) is used to produce central nervous system (CNS) pathology and behavioral deficits in rhesus monkeys reminiscent of those seen in humans infected with human immunodeficiency virus (HIV). The time course of disease progression was characterized by using functional measures of cognition and motor skill, as well as neurophysiologic monitoring. Concomitant assessment of immunological and virological parameters illustrated correspondence between impaired behavioral performance and viral pathogenesis. Convergent results were obtained from neuropathological findings indicative of significant CNS disease. In ongoing studies, this SIV model is being used to explore the behavioral sequelae of immunodeficiency virus infection, the viral and host factors leading to neurologic dysfunction, and to begin testing potential therapeutic agents.